Long-acting medicines for malaria, tuberculosis and hepatitis C
View More
Unitaid-funded projects develop innovative medicines, diagnostic tools and public health techniques and link them quickly, and at affordable prices, to those most in need.
Our grant projects apply the best that science has to offer to the fight against HIV and co-infections, tuberculosis and malaria in lower-resource countries.
Grant focus
To develop long-acting formulations of key medicines and create a market for them
Grantees
University of Liverpool
Status
Current
Amount
US$ 32,004,459
Disease
Hepatitis C, HIV and Co-Infection, Malaria, Tuberculosis
View More
Grant focus
The IMPACT project seeks to interrupt malaria transmission
Grantees
MedinCell
Status
Current
Amount
US$ 6,358,125
Disease
Malaria
View More
Grant focus
To evaluate the mass-distribution of ivermectin to humans and livestock in two African countries during the malaria season.
Grantees
Barcelona Institute for Global Health (ISGlobal)
Status
Current
Amount
US$ 25,316,950
Disease
Malaria
View More
Grant focus
To evaluate slow-release repellents that drive mosquitoes from inhabited areas
Grantees
University of Notre Dame
Status
Current
Amount
US$ 33,724,865
Disease
Malaria
View More
Grant focus
Overcome barriers to availability, quality and supply of medicines for severe malaria and malaria prevention
Grantees
Medicines for Malaria Venture (MMV)
Status
Current
Amount
US$ 3,361,023
Disease
Malaria
View More
Grant focus
Collect data to determine whether a large-scale introduction of a malaria vaccine in Africa is workable.
Grantees
World Health Organization
Status
Current
Amount
US$ 9,600,000
Disease
Malaria
View More
Grant focus
Provide pregnant women with intermittent doses of sulfadoxine-pyramethamine, a medicine that prevents malaria, and gather data on delivery through community health workers.
Grantees
Jhpiego
Status
Current
Amount
US$ 51,593,329
Disease
Malaria
View More